MabCure Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2007
2008
2009
2010
2011
Sales/Revenue
-
-
-
-
500.00
Cost of Goods Sold (COGS) incl. D&A
-
-
297.00
43.10
390.60
Gross Income
-
-
297.00
43.10
109.40
SG&A Expense
-
279.40
894.40
976.30
819.10
EBIT
106.30
536.00
1,359.50
1,019.40
709.70
Unusual Expense
-
-
-
-
11,373.20
Non Operating Income/Expense
-
0.50
-
-
4.80
Interest Expense
-
1.00
16.70
206.90
186.70
Pretax Income
106.30
530.50
1,371.90
1,225.80
12,264.80
Consolidated Net Income
106.30
530.50
1,371.90
1,225.80
12,264.80
Net Income
106.30
530.50
1,371.90
1,225.80
12,264.80
Net Income After Extraordinaries
106.30
530.50
1,371.90
1,225.80
12,264.80
Net Income Available to Common
106.30
530.50
1,371.90
1,225.80
12,264.80
EPS (Basic)
-
0.01
0.02
0.02
0.19
Basic Shares Outstanding
49,684.90
43,097.80
60,357.20
62,054.50
63,350.80
EPS (Diluted)
0.00
0.01
0.02
0.02
0.19
Diluted Shares Outstanding
49,684.90
43,097.80
60,357.20
62,054.50
63,350.80
EBITDA
106.30
531.90
1,318.60
976.30
677.10
Other Operating Expense
106.30
252.50
168.10
-
-
Non-Operating Interest Income
-
5.90
4.30
0.50
0.00
About MabCure
View Profile
